🔎 Trials Near Me

홈 › 비소세포폐암 › 캘리포니아

캘리포니아의 비소세포폐암 임상 시험

비소세포폐암 관련 연구 207개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.

캘리포니아의 도시

공식 연구 텍스트(영어)

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • Hoag Hospital Newport Beach, Newport Beach
  • University of California, Irvine Health, Orange
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06765109

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 9, La Jolla
  • ALX Center 11, Santa Monica
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07085091

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

  • Beverly Hills Cancer Center, Beverly Hills
  • Orange Coast Memorial Medical Center, Fountain Valley
  • Local Institution - 0027, Los Alamitos
  • 외 5개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07361510

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Kaiser Permanente-Anaheim, Anaheim
  • Kaiser Permanente-Deer Valley Medical Center, Antioch
  • Sutter Auburn Faith Hospital, Auburn
  • 외 56개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT04267848

Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC

  • Stanford University, Stanford
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT04585490

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

  • START LA, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • Valkyrie Clinical Trials, Los Angeles
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07659782

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

  • Tower Cancer Research Foundation, Beverly Hills
  • Cedars-Sinai Medical Center, Los Angeles
  • Cedars-Sinai Cancer - Tarzana, Tarzana
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07388524

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

  • Providence - St. Jude Medical Center /ID# 271414, Fullerton
  • FOMAT Medical Research - Clinica mi Salud by Focil Med /ID# 274450, Oxnard
  • UCLA - Santa Monica /ID# 271690, Santa Monica
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06772623

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Duarte
  • Research Site, Los Angeles
  • Research Site, Newport Beach
  • 외 1개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Los Angeles
  • PHN-012-001 Site, San Diego
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07127874

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  • MemorialCare Long Beach Medical Center, Long Beach
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06881784

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Tower Cancer Research Foundation, Beverly Hills
  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • 외 20개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06498635

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

  • Providence St. Jude Medical Center ( Site 0106), Fullerton
  • VA Long Beach Healthcare System ( Site 0199), Long Beach
  • USC Norris Comprehensive Cancer Center ( Site 0205), Los Angeles
  • 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06623422

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  • Alta Bates Summit Medical Center Comprehensive Cancer Center, Berkeley
  • John Muir Health Clinical Research Center, Concord
  • UC San Diego Medical Center - Encinitas, Encinitas
  • 외 16개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07144280

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

  • University of California at San Diego, La Jolla
  • University of California Irvine, Orange
  • Stanford Cancer Institute, Stanford
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05498428

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

  • UC Davis Comprehensive Cancer Center ( Site 3204), Sacramento
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07513376

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

  • Providence Medical Foundation, Fullerton
  • Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
  • Providence St. Jude Medical Center, Fullerton
  • 외 9개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07227298

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Oncura Health - Anaheim, Anaheim
  • Memorial Care Orange Coast Medical Center Attn, Fountain Valley
  • MemorialCare Orange Coast Medical Center, Fountain Valley
  • 외 20개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07222566

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, Duarte
  • Research Site, Los Angeles
  • Research Site, Newport Beach
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06218914

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Providence Medical Foundation, Fullerton
  • Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
  • Providence St. Jude Medical Center, Fullerton
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06758401

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

  • Research Site, La Mesa
  • Research Site, Los Alamitos
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06868277

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07154290

A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC

  • City of Hope, Duarte
  • City of Hope 1, Irvine
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07586202

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

  • Stanford Cancer Institute, Stanford
  • Stanford Hospital and Clinics, Stanford
  • Stanford Hospital Investigational Drug Services, Stanford
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07489066

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • The Oncology Institute of Hope and Innovation, Cerritos
  • City of Hope Corona, Corona
  • City of Hope, Duarte
  • 외 26개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06667076

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • University of California San Diego, La Jolla
  • Stanford University, Palo Alto
  • UCLA Medical Center, Santa Monica
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04981119

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  • City of Hope National Medical Center /ID# 277005, Duarte
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277928, Irvine
  • UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07155187

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Beverly Hills Cancer Center ( Site 0070), Beverly Hills
  • UCLA Clinical & Translational Research Center (CTRC) ( Site 0033), Los Angeles
  • Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
  • 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312137

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

  • Moores Cancer Center at UC San Diego Health, La Jolla
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06667908

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • City of Hope, Duarte
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06172478

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

  • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0130), Burbank
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06170788

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07229313

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  • UCLA Hematology/Oncology - Santa Monica, Los Angeles
  • Profound Research LLC, Oceanside
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
  • 외 3개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06890598

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Precision NextGen Oncology, Beverly Hills
  • OPN Healthcare, Inc, Glendale
  • University of Southern California, Los Angeles
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06047379

Pan-tumor MRD Study

  • Los Angeles Cancer Network (LACN), Glendale
  • Ventura County Hematology Oncology Specialists, Oxnard
  • Medical Oncology Associates of San Diego (MOASD), San Diego
  • 외 2개
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06605404

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

  • Research Site, Los Angeles
피험자 모집 중2상
18세 ~ 95세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05061550

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

  • Providence Medical Foundation - Fullerton - Virginia K. Crosson Cancer Center, Fullerton
  • University of California - Irvine, Orange
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07140016

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

  • Research Site, Anaheim
  • Research Site, Beverly Hills
  • Research Site, Fountain Valley
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06357533

Intratumoral N17350 in Advanced Solid Tumors

  • The Angeles Clinic and Research Institute, Los Angeles
  • UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
  • Scripps Clinic Torrey Pines - La Jolla, San Diego
  • 외 1개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07339176

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.